SARS-CoV-2 takes different variations to create new complications in our bodies. A novel study gives an improved picture of the genetic difference in people exhibiting severe infection of SARS-CoV-2. The study published in JAMA Network gives a bright view on the genetic variations in the TLR7 gene that results in severe illness in healthy men of younger ages during SARS-CoV-2 infection.
A Mutation In TLR7 Gene Is Associated With Severe SARS-CoV-2 Infection
TLR7 is abbreviated as Toll-like receptor 7. It is a type of protein enciphered in the human body also found in some birds and mammals.
The RNA expression of this protein is found in blood, the appendix, thymus, urinary bladder, spleen, placenta, and lung. The major functions of TLR7 are:
- It plays a major role in the immune response against the virus.
- Acts as a detector for innate immunity.
- Initiates interferon response.
- Manages inflammatory response.
- Helps in signal transduction.
- Enhances Cytokine production.
- Recognizes Coronavirus and triggers an immune response against it.
This study involved researchers from Radboud University, Maastricht University Medical Center, Erasmus Medical Center, and the University of Bonn. The main aim of the study was to analyze the role of proteins like TLR7 in viral infections and the adverse effect caused by mutations in them.
This Spanish-Dutch research was conducted based on three methodologies. They are:
- In vitro
- In silico
- Case study
The study was initiated by a case study of two sets of brothers, 4 men together who had no previous health complications but were seriously infected by SARS-CoV-2. The study became more complex when one among them dies because of the illness. Something which was found in union with them was a mutation in the TLR7 gene.
One set of brothers was found a mutation in TLR7 affecting the X chromosome and the second set was found a noxious gene. The age of the patients ranges between 21 to 30 years of age. The mutation caused in the TLR7 gene has resulted in the diminished activity of the protein against the virus.
Then the family members of these patients were tested for genetic variation. The method of working involved in this study was:
Exposure to imiquimod and heat-killed Candida albicans yeast.
Quantitative PCR (qPCR) assay
Peripheral mononuclear blood cell isolation.
Enzyme-Linked Immunosorbent Assay Measurements
Rapid whole-exome genome sequencing.
The research stated that mutation in the TLR7 gene has resulted in deprivation of its activity which in turn affected type I and II interferon responses.
After this discovery, scientists all around the world started to perform follow-up studies of this. A study performed by an Italian researcher found that 2% of the people critically affected by SARS-CoV-2 were carrying a mutated TLR7 gene. This study’s participants were men aged 60 and above. Another American study detected TLR7 as the most common factor for acute infection.
A new study also found that females are less prone to such kind of mutation compared to males which result in higher rates of acute illness in male. Females escape from TLR7 XCI – Toll-like Receptor X chromosomal inactivation in the embryonic stage whereas males are highly prone to TLR7 XCI.
This study can play a key role in protecting the People with mutated TLR7. This can help us identify people in need of high medical assistance. This can help us open new doors in COVID-19 studies and the basis of the chromosomal-linked differences.
This study also holds some drawbacks as only a limited amount of people were used to studying. Comparative studies with lead cases were performed only with parents of family 1 and no study was done with family 2. The method of working was done only with 1 male and 1 female.
This study was funded by the Solve-RD project, Spinoza Grant, European Research Council Advanced Grant, European Union’s Horizon 2020 research and innovation program, ZonMW Vidi grant, Sigrid Jusélius Foundation, and NWO.
- The Teen’s Parents Say She Was Denied A Kidney Transplant Because She Wasn’t Covid-Vaccinated - December 13, 2022
- Breakthrough Drug Revolutionizes Breast Cancer Treatment: Scientists Overjoyed - December 12, 2022
- Flint Water Crisis: The Judgment Exonerates The Former Governor Of Michigan From Any Prosecution - December 12, 2022